A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function

Francesco Casanova, Andrew R. Wood, Hanieh Yaghootkar, Robert N. Beaumont, Samuel E. Jones, Kim M. Gooding, Kunihiko Aizawa, W. David Strain, Andrew T. Hattersley, Faisel Khan, Angela C. Shore, Timothy M. Frayling, Jessica Tyrrell (Lead / Corresponding author)

Research output: Contribution to journalArticle

30 Downloads (Pure)

Abstract

Urinary albumin-creatinine ratio is a marker of diabetic nephropathy and microvascular damage. Metabolic-related traits are observationally associated with ACR but their causal role is uncertain. Here, we confirmed ACR as a marker of microvascular damage and tested whether metabolic-related traits have causal relationships with ACR.

The association between ACR and microvascular function (responses to acetylcholine and sodium nitroprusside) were tested in the SUMMIT study. Two sample Mendelian randomization (MR) was used to infer the causal effects of eleven metabolic risk factors, including glycemic, lipid and adiposity traits on ACR. MR was performed in up to 440,000 UK Biobank and 54,451 CKDGen participants.

ACR was robustly associated with microvascular function measures in SUMMIT. Using MR we inferred that higher triglyceride and LDL-cholesterol levels caused elevated ACR. A one standard deviation (SD) higher triglyceride and LDL-C level caused a 0.062 [95%CI: 0.040, 0.083] and a 0.026 [95%CI: 0.008, 0.044] SD higher ACR respectively. There was evidence that higher body fat and visceral body fat distribution caused elevated ACR, whilst a metabolically “favourable adiposity” phenotype lowered ACR.

ACR is a valid marker for microvascular function. MR suggested that 7 traits have causal effects on ACR, highlighting the role of adiposity related traits in causing lower microvascular function.
Original languageEnglish
JournalDiabetes
Early online date8 Jan 2020
DOIs
Publication statusE-pub ahead of print - 8 Jan 2020

Fingerprint

Adiposity
Dyslipidemias
Random Allocation
Albumins
Creatinine
Body Fat Distribution
Intra-Abdominal Fat
Diabetic Nephropathies
Nitroprusside
LDL Cholesterol
Acetylcholine
Adipose Tissue
Triglycerides
Phenotype
Lipids

Cite this

Casanova, Francesco ; Wood, Andrew R. ; Yaghootkar, Hanieh ; Beaumont, Robert N. ; Jones, Samuel E. ; Gooding, Kim M. ; Aizawa, Kunihiko ; Strain, W. David ; Hattersley, Andrew T. ; Khan, Faisel ; Shore, Angela C. ; Frayling, Timothy M. ; Tyrrell, Jessica. / A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function. In: Diabetes. 2020.
@article{976cace550574738b2aaccad1f09b41b,
title = "A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function",
abstract = "Urinary albumin-creatinine ratio is a marker of diabetic nephropathy and microvascular damage. Metabolic-related traits are observationally associated with ACR but their causal role is uncertain. Here, we confirmed ACR as a marker of microvascular damage and tested whether metabolic-related traits have causal relationships with ACR.The association between ACR and microvascular function (responses to acetylcholine and sodium nitroprusside) were tested in the SUMMIT study. Two sample Mendelian randomization (MR) was used to infer the causal effects of eleven metabolic risk factors, including glycemic, lipid and adiposity traits on ACR. MR was performed in up to 440,000 UK Biobank and 54,451 CKDGen participants.ACR was robustly associated with microvascular function measures in SUMMIT. Using MR we inferred that higher triglyceride and LDL-cholesterol levels caused elevated ACR. A one standard deviation (SD) higher triglyceride and LDL-C level caused a 0.062 [95{\%}CI: 0.040, 0.083] and a 0.026 [95{\%}CI: 0.008, 0.044] SD higher ACR respectively. There was evidence that higher body fat and visceral body fat distribution caused elevated ACR, whilst a metabolically “favourable adiposity” phenotype lowered ACR.ACR is a valid marker for microvascular function. MR suggested that 7 traits have causal effects on ACR, highlighting the role of adiposity related traits in causing lower microvascular function.",
author = "Francesco Casanova and Wood, {Andrew R.} and Hanieh Yaghootkar and Beaumont, {Robert N.} and Jones, {Samuel E.} and Gooding, {Kim M.} and Kunihiko Aizawa and Strain, {W. David} and Hattersley, {Andrew T.} and Faisel Khan and Shore, {Angela C.} and Frayling, {Timothy M.} and Jessica Tyrrell",
note = "{\circledC} 2020 by the American Diabetes Association.",
year = "2020",
month = "1",
day = "8",
doi = "10.2337/db19-0862",
language = "English",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association",

}

Casanova, F, Wood, AR, Yaghootkar, H, Beaumont, RN, Jones, SE, Gooding, KM, Aizawa, K, Strain, WD, Hattersley, AT, Khan, F, Shore, AC, Frayling, TM & Tyrrell, J 2020, 'A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function', Diabetes. https://doi.org/10.2337/db19-0862

A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function. / Casanova, Francesco; Wood, Andrew R.; Yaghootkar, Hanieh; Beaumont, Robert N.; Jones, Samuel E.; Gooding, Kim M.; Aizawa, Kunihiko; Strain, W. David; Hattersley, Andrew T.; Khan, Faisel; Shore, Angela C.; Frayling, Timothy M.; Tyrrell, Jessica (Lead / Corresponding author).

In: Diabetes, 08.01.2020.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Mendelian randomization study provides evidence that adiposity and dyslipidemia lead to lower urinary albumin creatinine ratio, a marker of microvascular function

AU - Casanova, Francesco

AU - Wood, Andrew R.

AU - Yaghootkar, Hanieh

AU - Beaumont, Robert N.

AU - Jones, Samuel E.

AU - Gooding, Kim M.

AU - Aizawa, Kunihiko

AU - Strain, W. David

AU - Hattersley, Andrew T.

AU - Khan, Faisel

AU - Shore, Angela C.

AU - Frayling, Timothy M.

AU - Tyrrell, Jessica

N1 - © 2020 by the American Diabetes Association.

PY - 2020/1/8

Y1 - 2020/1/8

N2 - Urinary albumin-creatinine ratio is a marker of diabetic nephropathy and microvascular damage. Metabolic-related traits are observationally associated with ACR but their causal role is uncertain. Here, we confirmed ACR as a marker of microvascular damage and tested whether metabolic-related traits have causal relationships with ACR.The association between ACR and microvascular function (responses to acetylcholine and sodium nitroprusside) were tested in the SUMMIT study. Two sample Mendelian randomization (MR) was used to infer the causal effects of eleven metabolic risk factors, including glycemic, lipid and adiposity traits on ACR. MR was performed in up to 440,000 UK Biobank and 54,451 CKDGen participants.ACR was robustly associated with microvascular function measures in SUMMIT. Using MR we inferred that higher triglyceride and LDL-cholesterol levels caused elevated ACR. A one standard deviation (SD) higher triglyceride and LDL-C level caused a 0.062 [95%CI: 0.040, 0.083] and a 0.026 [95%CI: 0.008, 0.044] SD higher ACR respectively. There was evidence that higher body fat and visceral body fat distribution caused elevated ACR, whilst a metabolically “favourable adiposity” phenotype lowered ACR.ACR is a valid marker for microvascular function. MR suggested that 7 traits have causal effects on ACR, highlighting the role of adiposity related traits in causing lower microvascular function.

AB - Urinary albumin-creatinine ratio is a marker of diabetic nephropathy and microvascular damage. Metabolic-related traits are observationally associated with ACR but their causal role is uncertain. Here, we confirmed ACR as a marker of microvascular damage and tested whether metabolic-related traits have causal relationships with ACR.The association between ACR and microvascular function (responses to acetylcholine and sodium nitroprusside) were tested in the SUMMIT study. Two sample Mendelian randomization (MR) was used to infer the causal effects of eleven metabolic risk factors, including glycemic, lipid and adiposity traits on ACR. MR was performed in up to 440,000 UK Biobank and 54,451 CKDGen participants.ACR was robustly associated with microvascular function measures in SUMMIT. Using MR we inferred that higher triglyceride and LDL-cholesterol levels caused elevated ACR. A one standard deviation (SD) higher triglyceride and LDL-C level caused a 0.062 [95%CI: 0.040, 0.083] and a 0.026 [95%CI: 0.008, 0.044] SD higher ACR respectively. There was evidence that higher body fat and visceral body fat distribution caused elevated ACR, whilst a metabolically “favourable adiposity” phenotype lowered ACR.ACR is a valid marker for microvascular function. MR suggested that 7 traits have causal effects on ACR, highlighting the role of adiposity related traits in causing lower microvascular function.

U2 - 10.2337/db19-0862

DO - 10.2337/db19-0862

M3 - Article

C2 - 31915152

JO - Diabetes

JF - Diabetes

SN - 0012-1797

ER -